Quest Diagnostics Inc vs GoPro Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while GoPro Inc trades at $0.63 (market cap $114.41M). The key difference: Quest Diagnostics Inc is far larger — about 229.1× GoPro Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while GoPro Inc pays none. Which is the better fit depends on your goals.
| DGX | GPRO | |
|---|---|---|
Market Cap | $26.21B | $114.41M |
Sector | Health | Technology |
52-Week High | $238.50 | $2.88 |
52-Week Low | $173.49 | $0.62 |
Enterprise Value | $31.97B | $173.19M |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →